Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology

Cited by (866)

Items 201–300 of 866

1. Exosomes from human lymphoblastoid B cells express enzymatically active CD38 that is associated with signaling complexes containing CD81, Hsc-70 and Lyn
   Esther Zumaquero, Pilar Muñoz, Marién Cobo, Gema Lucena, Esther J. Pavón, Ana Martín Algíbez, Pilar Navarro, Angélica García-Pérez, Adriana Ariza, Fabio Malavasi et al. · 2010 · Experimental Cell Research
2. An immunohistochemical, enzymatic, and behavioral study of CD157/BST-1 as a neuroregulator
   Haruhiro Higashida, Mingkun Liang, Toru Yoshihara, Shirin Akther, Azam A. K. M. Fakhrul, Черепанов Станислав Михайлович, Tae‐Sik Nam, Uh‐Hyun Kim, Satoka Kasai, Tomoko Nishimura et al. · 2017 · BMC Neuroscience
3. Roles and Modalities of Ectonucleotidases in Remodeling the Multiple Myeloma Niche
   Antonella Chillemi, Valeria Quarona, Luca Antonioli, Davide Ferrari, Alberto L. Horenstein, Fabio Malavasi · 2017 · Frontiers in Immunology
4. CD38 positively regulates postnatal development of astrocytes cell-autonomously and oligodendrocytes non-cell-autonomously: HATTORI et al.
   Hattori, Tsuyoshi, Kaji, Minoru, Ishii, Hiroshi, Jureepon, Roboon, Takarada-Iemata, Mika, Minh Ta, Hieu, Manh Le, Thuong, Konno, Ayumu, Hirai, Hirokazu, Shiraishi, Yoshitake et al. · 2017 · Glia
5. CD38 in the age of COVID-19: a medical perspective
   A. Horenstein, A. Faini, F. Malavasi · 2021 · Physiological Reviews
6. Chronic Lymphocytic Leukemia Cells Express CD38 in Response to Th1 Cell–Derived IFN-γ by a T-bet–Dependent Mechanism
   Simone Bürgler, Aleix Gimeno, Anna Parente-Ribes, Dong Wang, Audun Os, Stephen Devereux, Peter Jebsen, Bjarne Bogen, Geir Erland Tjønnfjord, Ludvig A. Munthe · 2014 · The Journal of Immunology
7. Chronic lymphocytic leukemia microenvironment: shifting the balance from apoptosis to proliferation
   Silvia Deaglio, Fabio Malavasi · 2009 · Haematologica
8. New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology
   Anne Roulston, Gordon C. Shore · 2015 · Molecular & Cellular Oncology
9. NAD+: A key metabolic regulator with great therapeutic potential
   Ghazal Sultani, Azrah Samsudeen, Brenna Osborne, Nigel A. Turner · 2017 · Journal of Neuroendocrinology
10. CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment: Modulation by Therapeutic Agents
    Federica Costa, Benedetta Dalla Palma, Nicola Giuliani · 2019 · Cells
11. Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma
    Kamlesh Kumar Bisht, Taro Fukao, Marielle Chiron, Paul Gerard Guy Richardson, Djordje Atanackovic, Eduardo N. Chini, Wee Joo Chng, Helgi J. Van de Velde, Fabio Malavasi · 2023 · Cancer Medicine
12. Vitamin A Deficiency Induces Autistic‐Like Behaviors in Rats by Regulating the RARβ‐CD38‐Oxytocin Axis in the Hypothalamus
    Xi Lai, Xiaofeng Wu, Nali Hou, Shu Liu, Qing Li, Ting Yang, Jingkun Miao, Zhifang Dong, Jie Chen, Tingyu Li · 2017 · Molecular Nutrition & Food Research
13. ImmunoPET imaging of CD38 in murine lymphoma models using 89Zr-labeled daratumumab
    Lei Kang, Dawei Jiang, Christopher G. England, Todd E. Barnhart, Bo Yu, Zachary T. Rosenkrans, Rongfu Wang, Jonathan W. Engle, Xiaojie Xu, Peng Huang et al. · 2018 · European Journal of Nuclear Medicine and Molecular Imaging
14. NAADP Receptors
    Anthony Galione · 2019 · Cold Spring Harbor Perspectives in Biology
15. CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells
    Orazio Fortunato, Dimas Carolina Belisario, Mara Compagno, Francesca Giovinazzo, Cristiano Bracci, Ugo Pastorino, Alberto L. Horenstein, Fabio Malavasi, Riccardo Ferracini, Stefania Scala et al. · 2020 · Frontiers in Immunology
16. The Effect of Progesterone Dose on Gene Expression after Traumatic Brain Injury
    G. Anderson, F. Farin, T. Bammler, R. Beyer, A. Swan, Hui-wen Wilkerson, E. Kantor, M. Hoane · 2011 · Journal of Neurotrauma
17. The NAD + -Dependent Family of Sirtuins in Cerebral Ischemia and Preconditioning
    Nathalie Khoury, Kevin B. Koronowski, Juan I. Young, Miguel A. Pérez‐Pinzón · 2017 · Antioxidants and Redox Signaling
18. CD38 as an immunotherapeutic target in multiple myeloma
    Francesca Bonello, Mattia D’Agostino, Maria Moscvin, Chiara Cerrato, Mario Boccadoro, Francesca Gay · 2018 · Expert Opinion on Biological Therapy
19. Deletion of CD38 Suppresses Glial Activation and Neuroinflammation in a Mouse Model of Demyelination
    Jureepon Roboon, Tsuyoshi Hattori, Hiroshi Ishii, Mika Takarada‐Iemata, Thuong Manh Le, Yoshitake Shiraishi, Noriyuki Ozaki, Yasuhiko Yamamoto, Akira Sugawara, Hiroshi Okamoto et al. · 2019 · Frontiers in Cellular Neuroscience
20. Connexin-43 Hemichannels Mediate Cyclic ADP-ribose Generation and Its Ca2+-mobilizing Activity by NAD+/Cyclic ADP-ribose Transport
    Eun-Kyung Song, So‐Young Rah, Young‐Rae Lee, Chae-Hwa Yoo, Yuri Kim, Ji-Hyun Yeom, Kwang‐Hyun Park, Jong‐Suk Kim, Uh‐Hyun Kim, Myung‐Kwan Han · 2011 · Journal of Biological Chemistry
21. Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) and Cyclic ADP-Ribose (cADPR) Mediate Ca2+ Signaling in Cardiac Hypertrophy Induced by β-Adrenergic Stimulation
    Rukhsana Gul, Dae‐Ryoung Park, Asif Iqbal Shawl, Soo-Yeul Im, Tae‐Sik Nam, Sun Hwa Lee, Jae-Ki Ko, Kyu Yun Jang, Donghee Kim, Uh‐Hyun Kim · 2016 · PLoS ONE
22. CD38 and CD157 Ectoenzymes Mark Cell Subsets in the Human Corneal Limbus
    Alberto L. Horenstein, Federico Sizzano, Riccardo Lusso, Federico Genzano Besso, Enza Ferrero, Silvia Deaglio, Franco Corno, Fabio Malavasi · 2009 · Molecular Medicine
23. Functional Mechanisms of Treg in the Context of HIV Infection and the Janus Face of Immune Suppression
    Jacobo López‐Abente, Rafael Correa‐Rocha, Marjorie Pion · 2016 · Frontiers in Immunology
24. Selegiline Ameliorates Depression-Like Behavior in Mice Lacking the CD157/BST1 Gene, a Risk Factor for Parkinson’s Disease
    Satoka Kasai, Toru Yoshihara, Olga L. Lopatina, Katsuhiko Ishihara, Haruhiro Higashida · 2017 · Frontiers in Behavioral Neuroscience
25. Prognostic value of antigen expression in multiple myeloma: a PETHEMA/GEM study on 1265 patients enrolled in four consecutive clinical trials
    on behalf of the GEM (Grupo Español de Mieloma)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) cooperative study group, Paula Arana, Bruno Paiva, M.‐T. Cedena, Noemí Puig, Lourdes Cordón, María‐Belén Vídriales, Norma Carmen Gutierrez, F Chiodi, Leire Burgos et al. · 2017 · Leukemia
26. The Roles of CD38 and CD157 in the Solid Tumor Microenvironment and Cancer Immunotherapy
    Yu Jun Wo, Adelia Shin Ping Gan, Xinru Lim, Isabel Shu Ying Tay, Sherlly Lim, Jeffrey Chun Tatt Lim, Joe Poh-Sheng Yeong · 2019 · Cells
27. Mitochondrial dysfunction and nicotinamide dinucleotide catabolism as mechanisms of cell death and promising targets for neuroprotection
    Tibor Kristián, Irina S. Balan, Rosemary A. Schuh, Mitch Onken · 2011 · Journal of Neuroscience Research
28. Targeting TRPM2 in ROS-Coupled Diseases
    Shinichiro Yamamoto, Shunichi Shimizu · 2016 · Pharmaceuticals
29. New Strategies in Multiple Myeloma: Immunotherapy as a Novel Approach to Treat Patients with Multiple Myeloma
    Paola E. Neri, Nizar Jacques Bahlis, Sagar Lonial · 2016 · Clinical Cancer Research
30. Identifying CD38+ cells in patients with multiple myeloma: first-in-human imaging using copper-64–labeled daratumumab
    Amrita Y. Krishnan, Vikram Adhikarla, Erasmus Kofi Poku, Joycelynne Michelle Palmer, Ammar Ahmed Chaudhry, Van Eric Biglang-awa, Nicole Bowles, Nitya Nathwani, Michael Alan Rosenzweig, Firoozeh Sahebi et al. · 2020 · Blood Advances
31. Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma
    Philippe Moreau, Niels W.C.J. van de Donk, Jesús F. San Miguel, Henk M. Lokhorst, Hareth Nahi, Dina Ben‐Yehuda, Michèle Cavo, Gordon Cook, Michel Delforge, Hermann Einsele et al. · 2016 · Drugs
32. CD38 produces nicotinic acid adenosine dinucleotide phosphate in the lysosome
    Cheng Fang, Ting Li, Ying Li, Guan Jie Xu, Qi Wen Deng, Ya Jie Chen, Yun Nan Hou, Hon Cheung Lee, Yong Juan Zhao · 2018 · Journal of Biological Chemistry
33. Targeting metabolic reprogramming in metastatic melanoma: The key role of nicotinamide phosphoribosyltransferase (NAMPT)
    Valentina Audrito, Antonella Managò, Federica Gaudino, Silvia Deaglio · 2019 · Seminars in Cell and Developmental Biology
34. NAD+ and cardiovascular diseases
    Qiuzhen Lin, Wanyun Zuo, Yaozhong Liu, Keke Wu, Qiming Liu · 2021 · Clinica Chimica Acta
35. A Novel NAD Signaling Mechanism in Axon Degeneration and its Relationship to Innate Immunity
    Eleanor L. Hopkins, Weixi Gu, Boštjan Kobe, Michael P. Coleman · 2021 · Frontiers in Molecular Biosciences
36. The role of CD38 in inflammation-induced depression-like behavior and the antidepressant effect of (R)-ketamine
    Xinying Zhang, Teng He, Zifeng Wu, Yuanyuan Wang, Hanyu Liu, Bingyuan Zhang, Siqi Yang, Di Wang, Chaoli Huang, Jiahao Duan et al. · 2023 · Brain Behavior and Immunity
37. Apigenin: a natural molecule at the intersection of sleep and aging
    Daniel J. Kramer, Adiv A. Johnson · 2024 · Frontiers in Nutrition
38. Interferon-Beta Induces Distinct Gene Expression Response Patterns in Human Monocytes versus T cells
    Noa Henig, Nili Avidan, Ilana Mandel, Elsebeth Staun-Ram, Elizabeta Ginzburg, Tamar Paperna, Ron Y. Pinter, Ariel Miller · 2013 · PLoS ONE
39. CD38/cADPR/Ca2+ Pathway Promotes Cell Proliferation and Delays Nerve Growth Factor-induced Differentiation in PC12 Cells
    Jianbo Yue, Wenjie Wei, Connie Mo Ching Lam, Yong Juan Zhao, Min Dong, Liangren Zhang, Lihe Zhang, Hon-Cheung Lee · 2009 · Journal of Biological Chemistry
40. Daratumumab for the treatment of multiple myeloma
    Cyrille Touzeau, Philippe Moreau · 2017 · Expert Opinion on Biological Therapy
41. Targeting NAD+ degradation: The therapeutic potential of flavonoids for Alzheimer's disease and cognitive frailty
    Qingwei Ruan, Jian Ruan, Weibin Zhang, Feng Qian, Zhuowei Yu · 2017 · Pharmacological Research
42. CD38 Deficiency Protects Heart from High Fat Diet-Induced Oxidative Stress Via Activating Sirt3/FOXO3 Pathway
    Ling-Fang Wang, Cong‐Cong Huang, Yun‐Fei Xiao, Xiao‐Hui Guan, Xiao‐Nv Wang, Qing Na Cao, Yu Liu, Xuan Huang, Libin Deng, Ke‐Yu Deng et al. · 2018 · Cellular Physiology and Biochemistry
43. An alternative method to dithiothreitol treatment for antibody screening in patients receiving daratumumab
    Amy E. Schmidt, Scott A. Kirkley, Nisha Patel, Debra Masel, Renee Bowen, Neil Blumberg, Majed A. Refaai · 2015 · Transfusion
44. CD38 knockout mice show significant protection against ischemic brain damage despite high level poly-ADP-ribosylation
    Long, Aaron, Park, Ji H., Klimova, Nina, Fowler, Carol, Loane, David J., Kristian, Tibor · 2017 · Neurochemical Research
45. CD38-Targeted Immunochemotherapy in Refractory Multiple Myeloma: A New Horizon
    Laubach, Jacob P., Richardson, Paul G. · 2015 · Clinical Cancer Research
46. CRISPR Gene Editing of Human Primary NK and T Cells for Cancer Immunotherapy
    Ezgi Elmas, Noushin Saljoughian, Marcelo de Souza Fernandes Pereira, Brian P. Tullius, Kinnari Sorathia, Robin J. Nakkula, Dean Anthony Lee, Meisam Naeimi Kararoudi · 2022 · Frontiers in Oncology
47. Cumulative Incidence and Relative Risk of Infection in Patients With Multiple Myeloma Treated With Anti-CD38 Monoclonal Antibody-Based Regimens: A Systematic Review and Meta-analysis
    Stephanos Vassilopoulos, Athanasios Vassilopoulos, Markos Kalligeros, Fadi Shehadeh, Eleftherios E Mylonakis · 2022 · Open Forum Infectious Diseases
48. Nicotinamide Phosphoribosyltransferase Inhibitors, Design, Preparation, and Structure–Activity Relationship
    Mette K. Christensen, Kamille Dumong Erichsen, Uffe H. Olesen, Jette Tjørnelund, Peter Fristrup, Annemette Thougaard, Søren Jensby Nielsen, Maxwell Sehested, Peter Buhl Jensen, Einārs Loža et al. · 2013 · Journal of Medicinal Chemistry
49. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients
    Esther J. Pavón, Esther Zumaquero, Antonio Rosal‐Vela, Keng Meng Khoo, Daniela Cerezo‐Wallis, Sonia García‐Rodríguez, Montserrat Carrascal, Joaquín Abián, Richard Milton Graeff, José Luís Callejas-Rubio et al. · 2013 · Cytokine
50. Deregulation of Adaptive T Cell Immunity in Multiple Myeloma: Insights Into Mechanisms and Therapeutic Opportunities
    Noémie Leblay, Ranjan Maity, Fajer Hasan, Paola E. Neri · 2020 · Frontiers in Oncology
51. Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma
    Jakub Radocha, Niels W.C.J. van de Donk, Katja Christina Weisel · 2021 · Cancers
52. Immunotherapy in Multiple Myeloma
    Cinnie Yentia Soekojo, Melissa Gaik Ming Ooi, Sanjay De Mel, Wee Joo Chng · 2020 · Cells
53. PD-1 expression on peripheral CD8+ TEM/TEMRA subsets closely correlated with HCV viral load in chronic hepatitis C patients
    Tao Shen, Jiajia Zheng, Chunhui Xu, Jia Liu, Weidong Zhang, Fengmin Lu, Hui Zhuang · 2010 · Virology Journal
54. Inhibition of CD38 with the Thiazoloquin(az)olin(on)e 78c Protects the Heart against Postischemic Injury
    Boslett, James, Reddy, Nikhil, Alzarie, Yasmin A, Zweier, Jay L · 2019 · The Journal of Pharmacology and Experimental Therapeutics
55. Basal CD38/cyclic ADP‐ribose‐dependent signaling mediates ATP release and survival of microglia by modulating connexin 43 hemichannels
    Yingxin Ma, Wei Jie Cao, Lu Wang, Jingwen Jiang, Hui Nie, Ban Wang, Xunbin Wei, Weihai Ying · 2014 · Glia
56. CD38-targeting antibodies in multiple myeloma: mechanisms of action and clinical experience
    Kristine A. Frerichs, Noemi Anna Nagy, Pieter L. Lindenbergh, Patty Bosman, Jhon A. Marin Soto, Marloes E.C. Broekmans, Richard W.J. Groen, Maria Themeli, Louise Nieuwenhuis, Claudia A.M. Stege et al. · 2018 · Expert Review of Clinical Immunology
57. Managing Infusion Reactions to New Monoclonal Antibodies in Multiple Myeloma: Daratumumab and Elotuzumab
    Ajay K. Nooka, Charise L. Gleason, Marva Ollivierre Sargeant, Michelle Walker, Melanie Watson, Elyse Hall Panjic, Sagar Lonial · 2018 · Journal of Oncology Practice
58. Multi-targeted Effect of Nicotinamide Mononucleotide on Brain Bioenergetic Metabolism
    Nina Klimova, Tibor Kristián · 2019 · Neurochemical Research
59. Adenosine metabolism in the vascular system
    Gennady G. Yegutkin · 2020 · Biochemical Pharmacology
60. Novel therapies for immune thrombocytopenia
    David J. Kuter · 2021 · British Journal of Haematology
61. Genetic Ablation of CD38 Protects against Western Diet-Induced Exercise Intolerance and Metabolic Inflexibility
    Shian-Huey Chiang, W. Wallace Harrington, Guizhen Luo, Naphtali O. Milliken, John C. Ulrich, Jing Chen, Deepak K. Rajpal, Ying Qian, Tiffany Y. Carpenter, Rusty Murray et al. · 2015 · PLoS ONE
62. Cord blood–derived T cells allow the generation of a more naïve tumor‐reactive cytotoxic T‐cell phenotype
    Julian Kwoczek, Sebastian B. Riese, Sabine Tischer, Szilvia Bak, Julia Lahrberg, Mathias Oelke, Holger Maul, Rainer Blasczyk, Martin G. Sauer, Britta Eiz‐Vesper · 2017 · Transfusion
63. New generation drugs for treatment of multiple myeloma
    Fehaid Ghali Alanazi, Faith A. A. Kwa, Genia Burchall, Denise E. Jackson · 2019 · Drug Discovery Today
64. BCMA-targeting Bispecific Antibody That Simultaneously Stimulates NKG2D-enhanced Efficacy Against Multiple Myeloma
    Yang Wang, Hui Joyce Li, Wei Feng Xu, Mingzhu Pan, Chun Qiao, Jialing Cai, Jingjing Xu, Min Wang, Juan Zhang · 2020 · Journal of Immunotherapy
65. Balancing NAD+ deficits with nicotinamide riboside: therapeutic possibilities and limitations
    Angelique Cercillieux, Eleonora Ciarlo, Carles Cantó · 2022 · Cellular and Molecular Life Sciences
66. A systems-approach to NAD+ restoration
    Nichola J. Conlon, Dianne Ford · 2022 · Biochemical Pharmacology
67. CD38: an ecto-enzyme with functional diversity in T cells
    Alip Ghosh, Arshi Khanam, Krishanu Ray, Poonam Mathur, Ananya Subramanian, Bhawna Poonia, Shyam Kottilil · 2023 · Frontiers in Immunology
68. CD38 antibody re-treatment in daratumumab-refractory multiple myeloma after time on other therapies
    Olivia Perez de Acha, Lauren T. Reiman, David S. Jayabalan, Zachary J. Walker, Grace Bosma, Alana L. Keller, Sarah E. Parzych, Diana Abbott, Beau M. Idler, Drew Ribadeneyra et al. · 2023 · Blood Advances
69. The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting
    Tiziana Vaisitti, Valentina Audrito, Sara Serra, Roberta Buonincontri, Giovanna Sociali, E. Mannino, Andrea Pagnani, Antonella Zucchetto, Erika Tissino, Candida Vitale et al. · 2014 · Leukemia
70. The ADP-ribosyl cyclases - the current evolutionary state of the ARCs
    M. Ferrero Enza · 2014 · Frontiers in bioscience
71. E2A is a transcriptional regulator of CD38 expression in chronic lymphocytic leukemia
    Ifigènia Saborit-Villarroya, Tiziana Vaisitti, Davide Rossi, Giovanni Francesco D'Arena, Gianluca Gaïdano, Fabio Malavasi, Silvia Deaglio · 2011 · Leukemia
72. An update on the biologics for the treatment of antiphospholipid syndrome
    Zelin Yun, Lizhi Duan, Xiangjun Liu, Qingmeng Cai, Chun Li · 2023 · Frontiers in Immunology
73. A Novel Role of CD38 and Oxytocin as Tandem Molecular Moderators of Human Social Behavior
    Serenella Tolomeo, Benjamin Chiao, Zhen Lei, Soo Hong Chew, Richard P. Ebstein · 2020 · Neuroscience & Biobehavioral Reviews
74. NAD+-consuming enzymes in immune defense against viral infection
    Jialin Shang, Michael R. Smith, Ananya Anmangandla, Hening Lin · 2021 · Biochemical Journal
75. Generation and characterization of a lysosomally targeted, genetically encoded Ca2+-sensor
    Hannah V. McCue, Joanna D. Wardyn, Robert D. Burgoyne, Lee P. Haynes · 2012 · Biochemical Journal
76. CD38 is highly expressed and affects the PI3K/Akt signaling pathway in cervical cancer
    SHAN LIAO, Songshu Xiao, Guangchao Zhu, Danwei Zheng, Junyu He, Zhen Pei, Guiyuan Li, Yanhong Zhou · 2014 · Oncology Reports
77. Targeting T-cell metabolism to boost immune checkpoint inhibitor therapy
    Haohao Li, Alison Zhao, Menghua Li, Lizhi Shi, Qiuju Han, Zhaohua Hou · 2022 · Frontiers in Immunology
78. Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Degradation by Alkaline Phosphatase
    Frederike Schmid, Ralf Fliegert, Tim Westphal, Andreas Bauche, Andreas H. Guse · 2012 · Journal of Biological Chemistry
79. Tetrameric Interaction of the Ectoenzyme CD38 on the Cell Surface Enables Its Catalytic and Raft-Association Activities
    Miki Hara‐Yokoyama, Mutsuko Kukimoto‐Niino, Kazue Terasawa, Satoru Harumiya, Katarzyna A. Podyma‐Inoue, Nobumasa Hino, Kensaku Sakamoto, Satsuki Itoh, Noritaka Hashii, Yoko Hiruta et al. · 2012 · Structure
80. Mice Deficient in CD38 Develop an Attenuated Form of Collagen Type II-Induced Arthritis
    Jorge Postigo, Marcos Iglesias, Daniela Cerezo‐Wallis, Antonio Rosal‐Vela, Sonia García‐Rodríguez, Mercedes Zubiaur, Jaime Sancho, Ramón Merino, Jesús Merino · 2012 · PLoS ONE
81. Investigational agents in immunotherapy: a new horizon for the treatment of multiple myeloma
    Cindy Varga, Jacob P. Laubach, Kenneth Carl Anderson, Paul Gerard Guy Richardson · 2018 · British Journal of Haematology
82. Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic Leukemia
    Alak Manna, Sonikpreet Aulakh, Prachi Jani, Salman Ahmed, Sharoon Akhtar, Marie V. Coignet, Michael G. Heckman, Zahara Meghji, Kirtipal Bhatia, Aarushi Sharma et al. · 2019 · Clinical Cancer Research
83. Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses
    Alak Manna, Timothy Kellett, Sonikpreet Aulakh, Laura J. Lewis‐Tuffin, Navnita Dutta, Keith L. Knutson, Eduardo N. Chini, Javier A. Pinilla-Ibarz, Nicole Lamanna, Rami Manochakian et al. · 2020 · Blood Advances
84. Oxytocin Signaling Pathway: From Cell Biology to Clinical Implications
    Michele Iovino, Tullio Messana, Anna Tortora, Consuelo Giusti, Giuseppe Lisco, Vito Angelo Giagulli, Edoardo Guastamacchia, Giovanni De Pergola, Vincenzo Triggiani · 2020 · Endocrine Metabolic & Immune Disorders - Drug Targets
85. Minireview Exploring the Biological Cycle of Vitamin B3 and Its Influence on Oxidative Stress: Further Molecular and Clinical Aspects
    Bogdan Doroftei, Ovidiu‐Dumitru Ilie, Roxana-Oana Cojocariu, Alin Stelian Ciobica, Radu Maftei, Delia Grab, Emil Anton, Jack McKenna, Nitasha Dhunna, Gabriela Simionescu · 2020 · Molecules
86. The Circular Life of Human CD38: From Basic Science to Clinics and Back
    Alberto L. Horenstein, Angelo Corso Faini, Fabio Morandi, Cristiano Bracci, Francesco Lanza, Nicola Giuliani, Aneel Paulus, Fabio Malavasi · 2020 · Molecules
87. Harnessing the Immune System Against Multiple Myeloma: Challenges and Opportunities
    Leona Yamamoto, Nicola Amodio, Annamaria Gullà, Kenneth Carl Anderson · 2021 · Frontiers in Oncology
88. Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis
    Giovanni O. Palladini, Paolo Milani, Fabio Malavasi, Giampaolo Merlini · 2021 · Cells
89. Emerging New Approaches in Desensitization: Targeted Therapies for HLA Sensitization
    Ashley Y. Choi, Miriam Manook, Danae Olaso, Brian Ezekian, Jae Berm Park, Kyle Freischlag, Annette M. Jackson, Stuart J. Knechtle, Jean Kwun · 2021 · Frontiers in Immunology
90. CD38 Deficiency Protects Mice from High Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Activating NAD+/Sirtuins Signaling Pathways-Mediated Inhibition of Lipid Accumulation and Oxidative Stress in Hepatocytes
    Lin Ying Xie, Ke Wen, Qian Li, Cong‐Cong Huang, Jia-Le Zhao, Qi‐Hang Zhao, Yun‐Fei Xiao, Xiao‐Hui Guan, Yisong Qian, Lu Gan et al. · 2021 · International Journal of Biological Sciences
91. Vitamin B3, the nicotinamide adenine dinucleotides and aging
    Ping Xu, Anthony A. Sauve · 2010 · Mechanisms of Ageing and Development
92. CD38 Facilitates Recovery from Traumatic Brain Injury
    Ayelet Levy, Adi Bercovich-Kinori, Alexander G. Alexandrovich, Jeanna Tsenter, Victoria Trembovler, Frances E. Lund, Esther Shohami, Reuven Stein, Lior Mayo · 2009 · Journal of Neurotrauma
93. Interaction of CD38 Variant and Chronic Interpersonal Stress Prospectively Predicts Social Anxiety and Depression Symptoms Over 6 Years
    Benjamin A. Tabak, Suzanne Vrshek‐Schallhorn, Richard E. Zinbarg, Jason M. Prenoveau, Susan Mineka, Eva E. Redei, Emma Kristine Adam, Michelle G. Craske · 2015 · Clinical Psychological Science
94. CD99 triggers upregulation of miR‐9‐modulated PRDM1/BLIMP1 in Hodgkin/Reed–Sternberg cells and induces redifferentiation
    Xueping Huang, Xinhua Zhou, Zhiqiang Wang, Feng Li, Fanrong Liu, Lin Zhong, Xiangzhao Li, Xi-qun Han, Ziqing Wu, Shaohong Chen et al. · 2011 · International Journal of Cancer
95. NAD Metabolome Analysis in Human Cells Using 1H NMR Spectroscopy
    Konstantin A. Shabalin, Kirill Nerinovski, Alexander P. Yakimov, Veronika Kulikova, Maria Svetlova, Ljudmila Solovjeva, Mikhail Khodorkovskiy, Stepan P. Gambaryan, Richard Cunningham, Marie E. Migaud et al. · 2018 · International Journal of Molecular Sciences
96. Functional Change of Effector Tumor-Infiltrating CCR5+CD38+HLA-DR+CD8+ T Cells in Glioma Microenvironment
    Pin‐Yuan Chen, Caren Yu-Ju Wu, Jian‐He Fang, Hsiu-Chi Chen, Li-Ying Feng, Chiung-Yin Huang, Kuo‐Chen Wei, Jia-You Fang, Chun‐Yen Lin · 2019 · Frontiers in Immunology
97. Cross-talk between CD38 and TTP Is Essential for Resolution of Inflammation during Microbial Sepsis
    Yeonsoo Joe, Yingqing Chen, Jeongmin Park, Hyo Jeong Kim, So‐Young Rah, Jinhyun Ryu, Gyeong Jae Cho, Hye‐Seon Choi, Stefan W. Ryter, Jeong Woo Park et al. · 2020 · Cell Reports
98. CD38 in cancer-associated fibroblasts promotes pro-tumoral activity
    Bar Ben Baruch, Einav Mantsur, Janusz Franco‐Barraza, Eran Blacher, Edna Cukierman, Reuven Stein · 2020 · Laboratory Investigation
99. Isatuximab for the treatment of relapsed/refractory multiple myeloma
    Paul Gerard Guy Richardson, Meral Beksaç, Ivan Špıčka, Joseph R Mikhael · 2020 · Expert Opinion on Biological Therapy
100. The Key Role of NAD+ in Anti-Tumor Immune Response: An Update
     Fabio Morandi, Alberto L. Horenstein, Fabio Malavasi · 2021 · Frontiers in Immunology